Helping to share the web since 1996
This is the first-ever Clinical Trial for a promising new drug, Inebilizumab, to treat anti-NMDA receptor encephalitis, and will be funded by the National Institutes of Health (NIH).
Upgrade OptionsThere are no posts for this page yet.
